Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis
Journal of Cardiovascular Electrophysiology · 2024
DOI: 10.1111/jce.16287 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Kenneth A Ellenbogen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Electrophysiology, Virginia Commonwealth University Health System, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Cardiac Pacing, Artificial, Bradycardia, Heart Rate, Action Potentials. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although left bundle branch area pacing (LBBAP) has been shown to be a feasible option for delivering physiological pacing, data are largely limited to single‐center reports. The aim of this analysis was to systematically assess the safety and efficacy of LBBAP with the Model 3830 lead among primarily bradycardia patients. Methods and Results PubMed, Embase, Cochrane Library, and Google Scholar were searched for full‐text articles on LBBAP using the SelectSecure Model 3830 lumenless lead. Rates and means were estimated using random‐ and mixed‐effects models. Of 3395 articles, 53 met inclusion criteria, representing 6061 patients undergoing an implant attempt. Average patient age was 68.1 years (95% CI: 66.6, 69.6) and 53.1% were male (95% CI: 50.5%, 55.7%). The average implant success rate among bradycardia‐indicated patients was 92.7% (95% CI: 89.5%, 94.9%). The overall estimated procedural adverse event rate was 2.5% (95% CI: 1.1%, 5.4%). The estimated septal perforation rate at implant was 1.6% (95% CI: 1.0%, 2.6%) with no adverse clinical sequelae reported. Pacing thresholds were low at implant (0.67 V [95% CI: 0.64, 0.70]) and remained stable through 12 months (0.76 V [95% CI: 0.72, 0.80]). Among bradycardia‐indicated patients, LVEF remained stable from baseline to post‐implant (59.5% [95% CI: 57.9%, 61.1%] vs. 60.1% [95% CI: 58.5%, 61.7%]).
Conclusion
This meta‐analysis including 6061 patients implanted with a Model 3830 lead for LBBAP found an average implant success rate of 92.7% and a procedural adverse event rate of 2.5% with stable electrical parameters and LVEF post‐implant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Electrophysiology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
- Medtronic, Inc., Mounds View, Minnesota, USA.
- Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, USA.
ORCID-Profile: Kenneth A Ellenbogen, Dedra H Fagan, Pugazhendhi Vijayaraman
Zitieren
APA
Ellenbogen, K. A., Fagan, D. H., Zimmerman, P., & Vijayaraman, P. (2024). Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16287
Vancouver
Ellenbogen KA, Fagan DH, Zimmerman P, Vijayaraman P. Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16287
BibTeX
@article{Ellenbogen2024,
author = {Ellenbogen, Kenneth A and Fagan, Dedra H and Zimmerman, Patrick and Vijayaraman, Pugazhendhi},
title = {Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2024},
doi = {10.1111/jce.16287}
}
EUVIMED